Merck & Co., Inc.

MRKNYSEUSD
110.97 USD
0.94 (0.86%)AT CLOSE (11:59 AM EDT)
110.68
0.62 (0.56%)
POST MARKET (AS OF 04:12 PM EDT)
Post Market
AS OF 04:12 PM EDT
110.68
0.62 (0.56%)
🟢Market: OPEN
Open?$108.55
High?$111.22
Low?$108.05
Prev. Close?$110.03
Volume?8.1M
Avg. Volume?9.7M
VWAP?$110.17
Rel. Volume?0.83x
Bid / Ask
Bid?$110.68 × 100
Ask?$110.69 × 100
Spread?$0.01
Midpoint?$110.69
Valuation & Ratios
Market Cap?271.8B
Shares Out?2.5B
Float?2.4B
Float %?98.2%
P/E Ratio?14.89
P/B Ratio?5.17
EPS?$7.39
Dividend?3.01%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.54Adequate
Quick Ratio?1.30Adequate
Cash Ratio?0.51Adequate
Debt/Equity?0.94Moderate
ValuationFAIRLY VALUED
Score
78/100
P/E?
14.9CHEAP
P/B?
5.17FAIR
P/S?
4.18FAIR
P/FCF?
22.0FAIR
EV/EBITDA?
11.0CHEAP
EV/Sales?
4.72FAIR
Returns & Efficiency
ROE?
34.7%STRONG
ROA?
13.3%STRONG
Cash Flow & Enterprise
FCF?$12.4B
Enterprise Value?$306.5B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Employees
75.0K
Market Cap
271.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-20
Address
126 EAST LINCOLN AVENUE
RAHWAY, NJ 07065
Phone: 908-740-4000